Publication:
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?

Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

Kocaturk, E.

Baskan, E. B.

Engin, B.

Ozdemir, M.

KÜÇÜK, ÖZLEM SU


Ornek, S.

Hasal, E.

Atakan, N.

Advisor

Date

2019-08-01T00:00:00Z

Language

Type

Conference Paper

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source

Keywords

Keywords

Kocaturk E., Baskan E. B. , Engin B., Ozdemir M., KÜÇÜK Ö. S. , Can P., Ornek S., Hasal E., Atakan N., -Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?-, Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, cilt.74, ss.484-485

Citation

URI

http://hdl.handle.net/20.500.12645/24428

Collections

Yayınlar - Eserler

Endorsement

Review

Supplemented By

Referenced By

3

Views

0

Downloads


Sustainable Development Goals